Ryan P. Million

1.2k total citations
15 papers, 944 citations indexed

About

Ryan P. Million is a scholar working on Genetics, Rheumatology and Hematology. According to data from OpenAlex, Ryan P. Million has authored 15 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Rheumatology and 5 papers in Hematology. Recurrent topics in Ryan P. Million's work include Chronic Lymphocytic Leukemia Research (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Ryan P. Million is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Ryan P. Million collaborates with scholars based in United States and Pakistan. Ryan P. Million's co-authors include Richard A. Van Etten, Robert Ilaria, Shaoguang Li, George Q. Daley, Tara Herrick, Jon C. Aster, D. Gary Gilliland, Nari Harakawa, S. A. Roumiantsev and Lyuba Varticovski and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Molecular and Cellular Biology.

In The Last Decade

Ryan P. Million

15 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan P. Million United States 11 503 340 298 193 163 15 944
Michael R. Burgess United States 16 586 1.2× 370 1.1× 272 0.9× 336 1.7× 154 0.9× 27 986
Roger Luo United States 16 510 1.0× 694 2.0× 229 0.8× 130 0.7× 185 1.1× 30 1.3k
Ton van Agthoven Netherlands 11 586 1.2× 528 1.6× 416 1.4× 216 1.1× 176 1.1× 13 1.2k
Marcus M. Schittenhelm Germany 16 767 1.5× 604 1.8× 358 1.2× 362 1.9× 123 0.8× 42 1.5k
J V Melo United Kingdom 17 839 1.7× 440 1.3× 644 2.2× 177 0.9× 390 2.4× 27 1.3k
Richard Smykla United States 11 224 0.4× 202 0.6× 165 0.6× 279 1.4× 90 0.6× 16 637
Frank Breitenbuecher Germany 18 811 1.6× 728 2.1× 393 1.3× 278 1.4× 56 0.3× 33 1.5k
Luc Van Rompaey Belgium 16 493 1.0× 568 1.7× 411 1.4× 594 3.1× 240 1.5× 31 1.4k
Vadym Zaberezhnyy United States 16 351 0.7× 704 2.1× 114 0.4× 214 1.1× 49 0.3× 25 1.1k
Rosalind H. Gunby Italy 13 267 0.5× 316 0.9× 222 0.7× 180 0.9× 141 0.9× 17 683

Countries citing papers authored by Ryan P. Million

Since Specialization
Citations

This map shows the geographic impact of Ryan P. Million's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan P. Million with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan P. Million more than expected).

Fields of papers citing papers by Ryan P. Million

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan P. Million. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan P. Million. The network helps show where Ryan P. Million may publish in the future.

Co-authorship network of co-authors of Ryan P. Million

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan P. Million. A scholar is included among the top collaborators of Ryan P. Million based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan P. Million. Ryan P. Million is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Million, Ryan P., et al.. (2015). Trends in breakthrough therapy designation. Nature Reviews Drug Discovery. 14(9). 597–598. 4 indexed citations
2.
Million, Ryan P., et al.. (2015). Monoclonal antibody biosimilars. Nature Reviews Drug Discovery. 15(1). 13–14. 34 indexed citations
3.
Million, Ryan P., et al.. (2014). Targeting the IL-17–TH17 pathway. Nature Reviews Drug Discovery. 14(1). 11–12. 70 indexed citations
4.
Million, Ryan P., et al.. (2013). The epigenetics pipeline. Nature Reviews Drug Discovery. 12(9). 661–662. 34 indexed citations
5.
Million, Ryan P., et al.. (2013). Antibody–drug conjugates. Nature Reviews Drug Discovery. 12(4). 259–260. 170 indexed citations
6.
Million, Ryan P., et al.. (2011). Personalized medicine in oncology: next generation. Nature Reviews Drug Discovery. 10(12). 895–896. 15 indexed citations
7.
Clark, Matthew & Ryan P. Million. (2009). Allergic rhinitis: market evolution. Nature Reviews Drug Discovery. 8(4). 271–272. 8 indexed citations
8.
Million, Ryan P.. (2008). Therapeutic area crossroads: anti-angiogenesis. Nature Reviews Drug Discovery. 7(2). 115–116. 6 indexed citations
9.
Herrick, Tara & Ryan P. Million. (2007). Tapping the potential of fixed-dose combinations. Nature Reviews Drug Discovery. 6(7). 513–514. 22 indexed citations
10.
Million, Ryan P.. (2006). Impact of genetic diagnostics on drug development strategy. Nature Reviews Drug Discovery. 5(6). 459–462. 11 indexed citations
11.
Million, Ryan P., Nari Harakawa, S. A. Roumiantsev, Lyuba Varticovski, & Richard A. Van Etten. (2004). A Direct Binding Site for Grb2 Contributes to Transformation and Leukemogenesis by the Tel-Abl (ETV6-Abl) Tyrosine Kinase. Molecular and Cellular Biology. 24(11). 4685–4695. 34 indexed citations
12.
Million, Ryan P., Jon C. Aster, D. Gary Gilliland, & Richard A. Van Etten. (2002). The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice. Blood. 99(12). 4568–4577. 37 indexed citations
13.
Million, Ryan P. & Richard A. Van Etten. (2000). The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood. 96(2). 664–670. 110 indexed citations
14.
Million, Ryan P. & Richard A. Van Etten. (2000). The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood. 96(2). 664–670. 7 indexed citations
15.
Li, Shaoguang, Robert Ilaria, Ryan P. Million, George Q. Daley, & Richard A. Van Etten. (1999). The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity. The Journal of Experimental Medicine. 189(9). 1399–1412. 382 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael R. Burgess Breakdown of academic impact, for papers by Roger Luo Breakdown of academic impact, for papers by Ton van Agthoven Breakdown of academic impact, for papers by Marcus M. Schittenhelm Breakdown of academic impact, for papers by J V Melo Breakdown of academic impact, for papers by Richard Smykla Breakdown of academic impact, for papers by Frank Breitenbuecher Breakdown of academic impact, for papers by Luc Van Rompaey Breakdown of academic impact, for papers by Vadym Zaberezhnyy Breakdown of academic impact, for papers by Rosalind H. Gunby
Rankless by CCL
2026